Filing Flows › Teladoc Health (TDOC) › Q3 2025
Teladoc Health (TDOC) Q3 2025 earnings results (third quarter 2025)
10-Q filed Oct 30, 2025
Teladoc Health (TDOC) reported revenue of $626M for the third quarter 2025 (Q3 2025), -2% from a year earlier and -0.9% from the quarter before. Operating margin was -8.3%, net loss $49.5M (7.9% of revenue).
Teladoc Health, Q3 2025: revenue $626M (-2% year over year), operating margin -8.3%, net loss $49.5M, operating cash flow $99.3M. The chart follows the revenue to costs, profit and cash.
| Q3 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $626M | -0.9% | -2% |
| Operating profit | −$52.0M | — | — |
| Net earnings | −$49.5M | — | — |
| Operating cash flow | $99.3M | +9% | -10% |
| Free cash flow | $97.0M | +8% | -11% |
What changed
Revenue was $626.4M in Q3 2025, down 2% year over year and down 1% from the previous quarter. Access Fees was the largest line at 83% of revenue. Access Fees lost $34.4M year over year (down 6%), 244% of the total change.
Operating costs exceeded revenue by $52.0M, an operating margin of -8.3%. Total costs fell 1% while revenue fell 2%. The quarter ended with a net loss of $49.5M, wider than the previous quarter's $32.7M loss.
Operating cash flow was $99.3M (down 10% year over year). Non-cash charges added back $17.0M of share-based compensation. Working capital and other items added $131.8M. Capital expenditures of $2.3M left free cash flow of $97.0M.
Questions
What was Teladoc Health's revenue in the third quarter 2025?
Teladoc Health (TDOC) reported revenue of $626M for the third quarter 2025 (Q3 2025), -2% from a year earlier and -0.9% from the quarter before.
Was Teladoc Health profitable in the third quarter 2025?
Operating loss was $52.0M (-8.3% of revenue) and net loss $49.5M.
Source: Teladoc Health 10-Q on SEC EDGAR.